Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.86 Billion USD | 8.27% |
| 2022 | 2.64 Billion USD | -8.88% |
| 2021 | 2.9 Billion USD | 0.89% |
| 2020 | 2.87 Billion USD | 2.51% |
| 2019 | 2.8 Billion USD | 22.53% |
| 2018 | 2.29 Billion USD | 13.78% |
| 2017 | 2.01 Billion USD | 41.17% |
| 2016 | 1.42 Billion USD | 13.64% |
| 2015 | 1.25 Billion USD | -6.27% |
| 2014 | 1.33 Billion USD | 223.28% |
| 2013 | 414.37 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.97 Billion USD | 3.78% |
| 2024 Q2 | 3.21 Billion USD | 8.12% |
| 2023 Q2 | 2.39 Billion USD | -8.6% |
| 2023 Q1 | 2.61 Billion USD | -1.12% |
| 2023 Q3 | 2.7 Billion USD | 13.17% |
| 2023 FY | 2.86 Billion USD | 8.27% |
| 2023 Q4 | 2.86 Billion USD | 5.85% |
| 2022 Q4 | 2.64 Billion USD | -21.49% |
| 2022 FY | 2.64 Billion USD | -8.88% |
| 2022 Q1 | 3.02 Billion USD | 4.03% |
| 2022 Q2 | 3.16 Billion USD | 4.84% |
| 2022 Q3 | 3.37 Billion USD | 6.42% |
| 2021 Q2 | 2.74 Billion USD | 3.67% |
| 2021 Q1 | 2.64 Billion USD | -8.17% |
| 2021 FY | 2.9 Billion USD | 0.89% |
| 2021 Q4 | 2.9 Billion USD | 1.02% |
| 2021 Q3 | 2.87 Billion USD | 4.9% |
| 2020 FY | 2.87 Billion USD | 2.51% |
| 2020 Q3 | 2.71 Billion USD | 0.76% |
| 2020 Q4 | 2.87 Billion USD | 5.97% |
| 2020 Q2 | 2.69 Billion USD | -3.98% |
| 2020 Q1 | 2.8 Billion USD | -0.01% |
| 2019 Q4 | 2.8 Billion USD | 5.57% |
| 2019 FY | 2.8 Billion USD | 22.53% |
| 2019 Q3 | 2.66 Billion USD | 1.26% |
| 2019 Q2 | 2.62 Billion USD | 1.38% |
| 2019 Q1 | 2.59 Billion USD | 13.07% |
| 2018 Q4 | 2.29 Billion USD | 2.7% |
| 2018 FY | 2.29 Billion USD | 13.78% |
| 2018 Q1 | 2.06 Billion USD | 2.46% |
| 2018 Q2 | 2.21 Billion USD | 7.11% |
| 2018 Q3 | 2.23 Billion USD | 0.94% |
| 2017 Q3 | 2.09 Billion USD | 18.29% |
| 2017 Q4 | 2.01 Billion USD | -3.69% |
| 2017 FY | 2.01 Billion USD | 41.17% |
| 2017 Q1 | 1.42 Billion USD | -0.29% |
| 2017 Q2 | 1.76 Billion USD | 24.28% |
| 2016 Q3 | 1.38 Billion USD | 2.09% |
| 2016 FY | 1.42 Billion USD | 13.64% |
| 2016 Q4 | 1.42 Billion USD | 2.91% |
| 2016 Q2 | 1.35 Billion USD | 6.4% |
| 2016 Q1 | 1.27 Billion USD | 1.66% |
| 2015 Q4 | 1.25 Billion USD | -10.2% |
| 2015 Q2 | 1.36 Billion USD | 4.63% |
| 2015 FY | 1.25 Billion USD | -6.27% |
| 2015 Q3 | 1.39 Billion USD | 2.47% |
| 2015 Q1 | 1.3 Billion USD | -2.65% |
| 2014 Q1 | 13.02 Million USD | 0.0% |
| 2014 FY | 1.33 Billion USD | 223.28% |
| 2014 Q4 | 1.33 Billion USD | 0.0% |
| 2013 FY | 414.37 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | -103.147% |
| Addus HomeCare Corporation | 110.39 Million USD | -2495.954% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -3105.266% |
| Amedisys, Inc. | 341.35 Million USD | -739.52% |
| Astrana Health, Inc. | 27.2 Million USD | -10432.951% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | -96.921% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 1293805.504% |
| biote Corp. | 25.86 Million USD | -10977.738% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -27218.495% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 24330.151% |
| COMPASS Pathways plc | -187.58 Million USD | 1627.656% |
| DocGo Inc. | -12.78 Million USD | 22507.531% |
| The Ensign Group, Inc. | 1.36 Billion USD | -110.454% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 26894.764% |
| InnovAge Holding Corp. | 56.08 Million USD | -5009.201% |
| The Joint Corp. | -2.47 Million USD | 115677.585% |
| LifeStance Health Group, Inc. | 432.21 Million USD | -563.022% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 47462.543% |
| ModivCare Inc. | 1.13 Billion USD | -151.977% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -1029065.125% |
| Option Care Health, Inc. | 822.56 Million USD | -248.387% |
| P3 Health Partners Inc. | 83.7 Million USD | -3323.489% |
| P3 Health Partners Inc. | 83.7 Million USD | -3323.489% |
| The Pennant Group, Inc. | 323.57 Million USD | -785.642% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 94616.044% |
| Talkspace, Inc. | -123.9 Million USD | 2412.764% |
| Talkspace, Inc. | -123.9 Million USD | 2412.764% |
| The Oncology Institute, Inc. | 86.32 Million USD | -3219.587% |
| The Oncology Institute, Inc. | 86.32 Million USD | -3219.587% |